Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is the safety and efficacy of Trastuzumab plus natural killer(NK) immunotherapy to recurrent breast cancer.
Epistemonikos ID: 8f480c485f80010717b9aed5a5ca54538604cc30
First added on: May 17, 2024